94 related articles for article (PubMed ID: 12167275)
21. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.
Jacobson LP; Jenkins FJ; Springer G; Muñoz A; Shah KV; Phair J; Zhang Z; Armenian H
J Infect Dis; 2000 Jun; 181(6):1940-9. PubMed ID: 10837173
[TBL] [Abstract][Full Text] [Related]
22. The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
Arastéh K; Hannah A
Oncologist; 2000; 5 Suppl 1():28-31. PubMed ID: 10804088
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
[TBL] [Abstract][Full Text] [Related]
24. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma.
Hamilton AS; Radka SF; Bernstein L; Gill PS; Gonsalves M; Naemura JR; Ross RK
J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):410-4. PubMed ID: 7907664
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus and human herpesvirus 8 DNA detection in peripheral blood monocytic cells of AIDS patients: correlations with the presence of Kaposi's sarcoma and CMV disease.
van der Kuyl AC; Polstra AM; van den Burg R; Jan Weverling G; Goudsmit J; Cornelissen M
J Med Virol; 2005 Aug; 76(4):541-6. PubMed ID: 15977227
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS.
Quinlivan EB; Wang RX; Stewart PW; Kolmoltri C; Regamey N; Erb P; Vernazza PL;
J Med Virol; 2001 Jun; 64(2):157-66. PubMed ID: 11360248
[TBL] [Abstract][Full Text] [Related]
27. Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma.
Stebbing J; Gazzard B; Newsom-Davis T; Nelson M; Patterson S; Gotch F; Mandalia S; Bower M
Int J Cancer; 2004 Jan; 108(3):473-4. PubMed ID: 14648716
[TBL] [Abstract][Full Text] [Related]
28. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor.
Weindel K; Marmé D; Weich HA
Biochem Biophys Res Commun; 1992 Mar; 183(3):1167-74. PubMed ID: 1567395
[TBL] [Abstract][Full Text] [Related]
29. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
Holzer G; Obermair A; Koschat M; Preyer O; Kotz R; Trieb K
Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature.
Albrecht H; Helm EB; Plettenberg A; Emminger C; Heise W; Schwartländer B; Stellbrink HJ
Genitourin Med; 1994 Dec; 70(6):394-8. PubMed ID: 7705856
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
32. Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipients.
Rosenzwajg M; Fery N; Bons V; Damaj G; Gluckman E; Gluckman J
Bone Marrow Transplant; 1999 Aug; 24(4):351-4. PubMed ID: 10467321
[TBL] [Abstract][Full Text] [Related]
33. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
34. Specific pattern of circulating endothelial adhesion molecules in HIV-associated Kaposi's sarcoma.
Becker K; Heins M; Südhoff T; Reinauer H; Häussinger D
Int Arch Allergy Immunol; 1997 Aug; 113(4):512-5. PubMed ID: 9250599
[TBL] [Abstract][Full Text] [Related]
35. Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients.
Chandra A; Demirhan I; Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Linde A; Heiden T; Biberfeld P; Doerr HW; Cinatl J; Loewer J; Chandra P
Anticancer Res; 2003; 23(1B):723-8. PubMed ID: 12680174
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
37. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
38. AIDS presenting with cutaneous Kaposi's sarcoma and bacillary angiomatosis in the bone marrow mimicking Kaposi's sarcoma.
Rosales CM; McLaughlin MD; Sata T; Katano H; Veno PA; de Las Casas LE; Miranda RN
AIDS Patient Care STDS; 2002 Dec; 16(12):573-7. PubMed ID: 12542930
[TBL] [Abstract][Full Text] [Related]
39. AIDS-associated Kaposi's sarcoma in Northeastern Nigeria.
Kagu MB; Nggada HA; Garandawa HI; Askira BH; Durosinmi MA
Singapore Med J; 2006 Dec; 47(12):1069-74. PubMed ID: 17139404
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
